• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form RW filed by Carmell Corporation

    10/15/24 4:30:02 PM ET
    $CTCX
    Medical/Dental Instruments
    Health Care
    Get the next $CTCX alert in real time by email
    RW 1 2024.10.15_rw_wd_09.23_s.htm RW RW

     

    Carmell Corporation

    2403 Sidney Street, Suite 300

    Pittsburgh, Pennsylvania 15203

     

    October 15, 2024

     

    VIA EDGAR CORRESPONDENCE

     

    U.S. Securities and Exchange Commission

    Division of Corporation Finance

    Office of Manufacturing

    100 F Street N.E.

    Washington, D.C. 20549

     

    Re: Carmell Corporation
    Request to Withdraw Registration Statement on Form S-1
    Filed August 7, 2023

    File No. 333-273781

     

    Ladies and Gentlemen:

     

    Pursuant to Rule 477 under the Securities Act of 1933, as amended (the “Securities Act”), Carmell Corporation (the “Registrant”) hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) consent to the withdrawal, effective as of the date hereof or at the earliest practicable date hereafter, of the Registrant’s Registration Statement on Form S-1 (File No. 333-273781) filed with the Commission on August 7, 2023, together with all exhibits thereto (collectively, the “Registration Statement”).

    The Registrant has decided not to pursue the offering due to business decisions and confirms that no securities covered by the Registration Statement have been issued or sold and that the Registration Statement has not been declared effective by the Commission. Based on the foregoing, the Registrant submits that the withdrawal of the Registration Statement is consistent with the public interest and the protection of investors.

    Pursuant to Rule 477(b) under the Securities Act, the Registrant understands that this request for withdrawal of the Registration Statement will be deemed granted as of the date hereof, unless the Registrant receives notice from the Commission within 15 days of the date hereof that such request will not be granted. In accordance with Rule 457(p) under the Securities Act, the Registrant requests that all fees paid to the Commission in connection with the filing of the Registration Statement be credited to the Registrant’s account for future use.

    We appreciate your time and attention to this matter. Should you have any questions, please call Michael A. Hedge with K&L Gates LLP, the Registrant’s outside counsel, at (949) 623-3519.

     

    Very truly yours,

     

     

     

    /s/ Bryan J. Cassaday

     

     

     

    Bryan J. Cassaday, Chief Financial Officer

     

    cc: Michael A. Hedge, K&L Gates LLP

     

     

     


    Get the next $CTCX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CTCX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CTCX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Chief Executive Officer Bracken-Ferguson Kendra

      4 - Carmell Corp (0001842939) (Issuer)

      11/8/24 5:13:51 PM ET
      $CTCX
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Director Gregory Kathryn

      4 - Carmell Corp (0001842939) (Issuer)

      11/8/24 5:00:05 PM ET
      $CTCX
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Chief Financial Officer Cassaday Bryan J.

      4 - Carmell Corp (0001842939) (Issuer)

      11/8/24 5:00:12 PM ET
      $CTCX
      Medical/Dental Instruments
      Health Care

    $CTCX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Upton Richard A bought $2,336 worth of shares (5,000 units at $0.47), increasing direct ownership by 50% to 15,000 units (SEC Form 4)

      4 - Carmell Corp (0001842939) (Issuer)

      9/16/24 4:30:07 PM ET
      $CTCX
      Medical/Dental Instruments
      Health Care
    • Director Frisch Scott M. bought $515 worth of shares (1,009 units at $0.51) (SEC Form 4)

      4 - Carmell Corp (0001842939) (Issuer)

      9/10/24 4:30:11 PM ET
      $CTCX
      Medical/Dental Instruments
      Health Care
    • Director Gregory Kathryn bought $643 worth of shares (1,260 units at $0.51) (SEC Form 4)

      4 - Carmell Corp (0001842939) (Issuer)

      9/10/24 4:30:16 PM ET
      $CTCX
      Medical/Dental Instruments
      Health Care

    $CTCX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • CARMELL CORP REBRANDS AS LONGEVITY HEALTH HOLDINGS TO HIGHLIGHT BUSINESS FOCUS & GROWTH STRATEGY

      Pittsburgh, PA, March 10, 2025 (GLOBE NEWSWIRE) -- PITTSBURGH, Mar. 10, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX, CTCXW)), a bio-aesthetics company (the "Company", "we", "our", or "us"), today announced a comprehensive corporate rebranding initiative aimed at better aligning the Company's market and investor facing image with its business focus and growth strategy. As part of the rebranding, the Company has changed its corporate name to "Longevity Health Holdings, Inc." and, at the open of trading on March 10, 2025, the Company's common stock and redeemable warrants will begin trading under the symbols "XAGE" and "XAGEW", respectively. The Company has also launc

      3/10/25 8:30:00 AM ET
      $CTCX
      Medical/Dental Instruments
      Health Care
    • Carmell Announces Closing of Elevai Skincare Acquisition

      PITTSBURGH, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX), a bio-aesthetics company focused on skin and hair health ("Carmell", the "Company", "we", "our", or "us"), today announced the closing of the previously announced acquisition of the skin and hair care business of Elevai Skincare, Inc. ("Elevai"), a leader in physician dispensed exosome skin and hair care products, pursuant to a definitive purchase agreement with PMGC Holdings Inc. (formerly Elevai Labs Inc.) ("PMGC") and Elevai, its wholly owned subsidiary (the "Acquisition"). At the closing of the Acquisition (the "Closing"), the purchase consideration consisted of the following: Approximately $1.1 mill

      1/16/25 8:00:28 AM ET
      $CTCX
      Medical/Dental Instruments
      Health Care
    • Carmell Announces Closing of Previously Announced PIPE Investment from Existing and New Investors to Support Commercial Build-out

      PITTSBURGH, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX), a bio-aesthetics company focused on skin and hair health ("Carmell", the "Company", "we", "our", or "us"), today announced the closing of its previously announced private placement with new and existing investors pursuant to a securities purchase agreement, dated December 23, 2024, for the issuance and sale of 8,065,210 shares of its common stock and an equal number of five-year warrants both priced at $0.23 per share, in a private placement for aggregate gross proceeds of $1.85 million before deducting offering expenses and fees (the "Private Placement"). The Private Placement was priced at a slight premium t

      1/3/25 8:00:03 AM ET
      $CTCX
      Medical/Dental Instruments
      Health Care

    $CTCX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Carmell Corporation

      SC 13G/A - Carmell Corp (0001842939) (Subject)

      12/6/24 4:16:05 PM ET
      $CTCX
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Carmell Corporation

      SC 13G/A - Carmell Corp (0001842939) (Subject)

      11/14/24 2:48:40 PM ET
      $CTCX
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Carmell Corporation (Amendment)

      SC 13G/A - Carmell Corp (0001842939) (Subject)

      4/18/24 3:03:07 PM ET
      $CTCX
      Medical/Dental Instruments
      Health Care

    $CTCX
    SEC Filings

    See more
    • SEC Form 424B3 filed by Carmell Corporation

      424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)

      3/26/25 5:01:17 PM ET
      $CTCX
      Medical/Dental Instruments
      Health Care
    • Carmell Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Longevity Health Holdings, Inc. (0001842939) (Filer)

      3/26/25 5:00:09 PM ET
      $CTCX
      Medical/Dental Instruments
      Health Care
    • SEC Form 424B3 filed by Carmell Corporation

      424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)

      3/10/25 8:53:40 AM ET
      $CTCX
      Medical/Dental Instruments
      Health Care

    $CTCX
    Leadership Updates

    Live Leadership Updates

    See more
    • CARMELL CORP REBRANDS AS LONGEVITY HEALTH HOLDINGS TO HIGHLIGHT BUSINESS FOCUS & GROWTH STRATEGY

      Pittsburgh, PA, March 10, 2025 (GLOBE NEWSWIRE) -- PITTSBURGH, Mar. 10, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX, CTCXW)), a bio-aesthetics company (the "Company", "we", "our", or "us"), today announced a comprehensive corporate rebranding initiative aimed at better aligning the Company's market and investor facing image with its business focus and growth strategy. As part of the rebranding, the Company has changed its corporate name to "Longevity Health Holdings, Inc." and, at the open of trading on March 10, 2025, the Company's common stock and redeemable warrants will begin trading under the symbols "XAGE" and "XAGEW", respectively. The Company has also launc

      3/10/25 8:30:00 AM ET
      $CTCX
      Medical/Dental Instruments
      Health Care
    • Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index

      PITTSBURGH, July 29, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX), a bio-aesthetics company focused on skin and hair health ("Company" or "Carmell"), today announced the appointment of Ms. Kendra Bracken-Ferguson as Chief Executive Officer effective July 30, 2024 with Mr. Rajiv Shukla continuing to serve as Executive Chairman of the Company. Kendra's appointment comes at a pivotal moment of growth for the Company. Since its business combination in July 2023, the Company has completed a pivot towards skincare, recruited a top-tier Scientific Advisory Board, developed and tested 12 skincare products aimed at retail and medspa use, scaled up in-house manufacturing and packagi

      7/29/24 8:30:00 AM ET
      $CTCX
      Medical/Dental Instruments
      Health Care
    • Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary

      PITTSBURGH, March 20, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX), a bio-aesthetics company focused on skin and hair health ("Carmell", the "Company", "we", "our", or "us"), today announced the execution of a definitive agreement to sell its wholly owned subsidiary, Axolotl Biologix ("AxoBio") to the initial sellers of AxoBio for 3,845,337 shares of Carmell common stock, 4,243 shares of Carmell preferred stock and notes payable to the initial sellers in the aggregate amount of $8 million. "The sale of AxoBio enables our exit from the tissue graft space thereby facilitating a sharper organizational focus on the launch of our skincare products beginning in March 2024 and co

      3/20/24 4:39:36 PM ET
      $CTCX
      Medical/Dental Instruments
      Health Care